Wockhardt posts 254 per cent growth in PAT at Rs 453 crores in Q2 of 2012-13
Reports 29 per cent growth in revenues at Rs 1347 crores
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Suven Life Sciences’ posts un-audited financial results for the quarter ended September 30,…
PAT up by 153 per cent
Alacris Theranostics enters agreement with GSK
To use ModCell System for early stage cancer research
Pharmexcil spells out clarifications from MoH&FW
Pharma exports, imports, med devices not covered by October notification
Sun Pharma to acquire DUSA Pharmaceuticals
A 100 per cent subsidiary of Sun Pharmaceutical Industries will commence a tender offer for all of the outstanding common stock of…
Indegene to acquire marketing services business assets of Canada-based Aptilon
To help clients accelerate their physician engagement strategies
Cipla announces major price reduction on select cancer drugs
Cipla Palliative Care Centre completes 15 years of caring for advanced stage cancer patients
Sun Pharma to acquire DUSA Pharmaceuticals
DUSA’s Levulan combination therapy is for treatment of non-hyperkeratotic actinic keratoses